Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ: TMCI )

6.960 +0.060 (+0.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 319,051
Open 6.900
Bid (Size) 6.520 (1)
Ask (Size) 7.380 (5)
Prev. Close 6.900
Today's Range 6.770 - 7.110
52wk Range 3.920 - 15.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE

Performance

YTD
-44.59%
-44.59%
1 Month
-12.34%
-12.34%
3 Month
+31.57%
+31.57%
6 Month
+20.21%
+20.21%
1 Year
-42.62%
-42.62%

More News

Read More
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Earnings Preview For Treace Medical Concepts
Via Benzinga
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Appoints Guy Guglielmino as Chief Commercial Officer
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation at Stifel 2024 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Via Benzinga
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the UBS Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
From Treace Medical Concepts, Inc.
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.